Point-of-care coagulation testing and transfusion algorithms.
暂无分享,去创建一个
[1] B. Spiess,et al. Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies , 2004, Journal of Clinical Monitoring.
[2] G. Nuttall,et al. Efficacy of a Simple Intraoperative Transfusion Algorithm for Nonerythrocyte Component Utilization after Cardiopulmonary Bypass , 2001, Anesthesiology.
[3] P. Moerloose,et al. Point of care and central laboratory determinations of the aPTT are not interchangeable in surgical intensive care patients , 2001, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[4] R. McCarthy,et al. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay. , 1994, Journal of cardiothoracic and vascular anesthesia.
[5] R. Davidson,et al. Description of an In Vitro Platelet Function Analyzer-PFA-100™ , 1995, Seminars in Thrombosis & Hemostasis.
[6] A. Hanke,et al. Perioperative Coagulation Management and Control of Platelet Transfusion by Point-of-Care Platelet Function Analysis , 2007, Transfusion Medicine and Hemotherapy.
[7] D. Royston,et al. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. , 2001, British journal of anaesthesia.
[8] D. Graham. Detailed diagnoses and procedures for patients discharged from short-stay hospitals. , 1988, Vital and health statistics. Series 13, Data from the National Health Survey.
[9] J. T. ten Berg,et al. The use of the VerifyNow system to monitor antiplatelet therapy: A review of the current evidence , 2008, Platelets.
[10] J. Albes,et al. Cost reduction of perioperative coagulation management in cardiac surgery: value of "bedside" thrombelastography (ROTEM). , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[11] P. Berguson,et al. Blood transfusion requirements in coronary artery surgery with and without the activated clotting time (ACT) technique , 1985, Klinische Wochenschrift.
[12] B. Spiess,et al. Transfusion of Blood Products Affects Outcome in Cardiac Surgery , 2004, Seminars in cardiothoracic and vascular anesthesia.
[13] R. Carroll,et al. Comparison of modified Thrombelastograph and Plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients. , 2005, The Journal of laboratory and clinical medicine.
[14] C. Hofer,et al. Coagulation Monitoring: Current Techniques and Clinical Use of Viscoelastic Point-of-Care Coagulation Devices , 2008, Anesthesia and analgesia.
[15] R. Kekomäki,et al. On‐site coagulation monitoring does not affect hemostatic outcome after cardiac surgery , 2001, Acta anaesthesiologica Scandinavica.
[16] M. Laato,et al. Use of activated clotting time to monitor anticoagulation during cardiac surgery. , 1984, Scandinavian journal of thoracic and cardiovascular surgery.
[17] A. Civelek,et al. Thromboelastography‐Based Transfusion Algorithm Reduces Blood Product Use after Elective CABG: A Prospective Randomized Study , 2009, Journal of cardiac surgery.
[18] R. Hetzer,et al. Evaluation of post-cardiopulmonary bypass coagulation disorders by differential diagnosis with a multichannel modified thromboelastogram: a pilot investigation. , 2001, The journal of extra-corporeal technology.
[19] M. Kuro,et al. Evaluation of Platelet Function by Sonoclot Analysis Compared with Other Hemostatic Variables in Cardiac Surgery , 1998, Anesthesia and analgesia.
[20] D. Jobes,et al. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. , 1995, The Journal of thoracic and cardiovascular surgery.
[21] M. Abdelnoor,et al. Assessment of heparin anticoagulation: comparison of two commercially available methods. , 1999, The Annals of thoracic surgery.
[22] G. Janvier,et al. Reproductibilité et interchangeabilité du Thromboélastographe®, Sonoclot® et du temps de coagulation activé (Hémochron®), en chirurgie cardiaque , 2001 .
[23] I. Yada,et al. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. , 1989, Journal of cardiothoracic anesthesia.
[24] W. Hauck,et al. Changes in blood coagulation during and following cardiopulmonary bypass: lack of correlation with clinical bleeding. , 1996, American journal of clinical pathology.
[25] B. Spiess,et al. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. , 1995, Journal of cardiothoracic and vascular anesthesia.
[26] M. Lordkipanidzé,et al. Assessment of VerifyNow P2Y12 Assay Accuracy in Evaluating Clopidogrel-Induced Platelet Inhibition , 2008, Therapeutic drug monitoring.
[27] C. Cerletti,et al. Platelet function, antiplatelet therapy and clinical outcomes: to test or not to test? , 2007, Journal of thrombosis and haemostasis : JTH.
[28] Fun-Gee Chen,et al. Prediction of excessive bleeding after coronary artery bypass graft surgery: the influence of timing and heparinase on thromboelastography. , 2002, Journal of cardiothoracic and vascular anesthesia.
[29] G. Despotis,et al. Optimal Management of Bleeding Complications After Cardiac Surgery , 2001 .
[30] C. Eby,et al. Risks associated with bleeding and transfusion: rationale for the optimal management of bleeding after cardiac surgery , 2007 .
[31] K. Maquelin,et al. Disappearance of glycoprotein Ib from the platelet surface in pericardial blood during cardiopulmonary bypass. , 1998, The Journal of thoracic and cardiovascular surgery.
[32] W. Dietrich,et al. The Predictive Value of Modified Computerized Thromboelastography and Platelet Function Analysis for Postoperative Blood Loss in Routine Cardiac Surgery , 2003, Anesthesia and analgesia.
[33] P. Kolh,et al. Guideline on antiplatelet and anticoagulation management in cardiac surgery. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[34] M. DePerio,et al. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. , 1999, Anesthesia and analgesia.
[35] F. Spinale,et al. Identification of patients at risk for excessive blood loss during coronary artery bypass surgery: thromboelastography versus coagulation screen. , 1993, Anesthesia and analgesia.
[36] A. Brill,et al. Using Cone and Plate(let) Analyzer to Predict Bleeding in Cardiac Surgery , 2006, Asian cardiovascular & thoracic annals.
[37] L. Goodnough,et al. The Variability of Transfusion Practice in Coronary Artery Bypass Surgery , 1991 .
[38] L. Shore-lesserson,et al. Coagulation monitoring. , 2006, Anesthesiology clinics.
[39] S. Bélisle,et al. [Reproducibility and interchangeability of the Thromboelastograph, Sonoclot and Hemochron activated coagulation time in cardiac surgery]. , 2001, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[40] D. Birnbaum,et al. Are In-Vitro Platelet Function Tests Useful in Predicting Blood Loss Following Open Heart Surgery? , 1998, The Thoracic and cardiovascular surgeon.
[41] G. Gravlee,et al. Heparin management protocol for cardiopulmonary bypass influences postoperative heparin rebound but not bleeding. , 1992, Anesthesiology.
[42] L. Goodnough,et al. The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group. , 1991, JAMA.
[43] M. Steiner,et al. Transfusion algorithms and how they apply to blood conservation: the high-risk cardiac surgical patient. , 2007, Hematology/oncology clinics of North America.
[44] A. Schwartz,et al. Monitoring heparin anticoagulation and its neutralization. , 1981, The Annals of thoracic surgery.
[45] Paul B. Watkins,et al. Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation: A New Drug–Drug Interaction , 2003, Circulation.
[46] J. Hirsh. Drug therapy : heparin , 1991 .
[47] R. Pokras. Detailed diagnoses and procedures for patients discharged from short-stay hospitals. United States, 1985. , 1987, Vital and health statistics. Series 13, Data from the National Health Survey.
[48] E. Spitznagel,et al. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. , 1994, The Journal of thoracic and cardiovascular surgery.
[49] O. Pradier,et al. Does the platelet function analyser (PFA-100) predict blood loss after cardiopulmonary bypass? , 2003, British Journal of Anaesthesia.
[50] I. Björk,et al. Mechanism of the anticoagulant action of heparin , 1982, Molecular and Cellular Biochemistry.
[51] Justin T. Newcomer,et al. Evaluation of Dose-Related Effects of Aspirin on Platelet Function: Results From the Aspirin-Induced Platelet Effect (ASPECT) Study , 2007, Circulation.
[52] D. Ekouevi,et al. Platelet function point-of-care tests in post-bypass cardiac surgery: are they relevant? , 2002, British journal of anaesthesia.
[53] H. Hartert,et al. The physical and biological constants of thrombelastography , 1962 .
[54] N. Neerchal,et al. Evaluation of Dose-Related Effects of Aspirin on Platelet Function: Results From the Aspirin-Induced Platelet Effect (ASPECT) Study , 2007 .
[55] A. Lefemine,et al. Activated clotting time for control of anticoagulation during surgery. , 1985, The American surgeon.
[56] J. Essell,et al. Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass. , 1993, Journal of cardiothoracic and vascular anesthesia.
[57] J. Roth,et al. Use of activated coagulation time to monitor heparin during cardiac surgery. , 1979, The Annals of thoracic surgery.
[58] B. Spiess,et al. Comparison of Viscoelastic Measures of Coagulation after Cardiopulmonary Bypass , 1989, Anesthesia and analgesia.
[59] L. Goodnough,et al. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. , 1997, Clinical chemistry.
[60] R. Carroll,et al. A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. , 2004, The Journal of laboratory and clinical medicine.
[61] C. Samama,et al. Near‐patient testing of haemostasis in the operating theatre: an approach to appropriate use of blood in surgery , 2003, Vox sanguinis.
[62] B. Akl,et al. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass. , 1980, The Journal of thoracic and cardiovascular surgery.
[63] G. Chatellier,et al. A Study of Platelet Functions with a New Analyzer Using High Shear Stress (PFA100™) in Patients Undergoing Coronary Artery Bypass Graft , 2000, Thrombosis and Haemostasis.
[64] L. Harker,et al. Bleeding complications associated with cardiopulmonary bypass. , 1990, Blood.
[65] J. Ostrowsky,et al. Plateletworks™ Platelet Function Test Compared to the Thromboelastograph™ for Prediction of Postoperative Outcomes , 2004, The Journal of ExtraCorporeal Technology.
[66] S. Body,et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes , 2004, Transfusion.
[67] A. Gori,et al. Different methodologies for evaluating the effect of clopidogrel on platelet function in high‐risk coronary artery disease patients , 2007, Journal of thrombosis and haemostasis : JTH.
[68] A. Greinacher,et al. Antigen Generation in Heparin-Associated Thrombocytopenia: The Nonimmunologic Type and the Immunologic Type Are Closely Linked in Their Pathogenesis , 1995, Seminars in thrombosis and hemostasis.
[69] J H Lewis,et al. Intraoperative Changes in Blood Coagulation and Thrombelastographic Monitoring in Liver Transplantation , 1985, Anesthesia and analgesia.
[70] C. Kaufmann,et al. Usefulness of thrombelastography in assessment of trauma patient coagulation. , 1997, The Journal of trauma.
[71] K. Rådegran,et al. Use of the activated coagulation time in cardiac surgery. Effects on heparin-protamine dosages and bleeding. , 1981, Scandinavian journal of thoracic and cardiovascular surgery.
[72] J. Caprini,et al. Comparison of Thrombelastography with Common Coagulation Tests , 1981, Thrombosis and Haemostasis.
[73] M. Avidan,et al. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. , 2004, British journal of anaesthesia.
[74] N. Savion,et al. Impact – The Cone and Plate(let) Analyzer: Testing Platelet Function and Anti-Platelet Drug Response , 2006, Pathophysiology of Haemostasis and Thrombosis.
[75] A. Gori,et al. Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment. , 2007, American journal of clinical pathology.
[76] C. Greenberg,et al. Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100® platelet function analyzer , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[77] J. Mathew,et al. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. , 1991, Anesthesiology.
[78] Sibu P Saha,et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. , 2007, The Annals of thoracic surgery.
[79] R. Scharpf,et al. Utility of Whole Blood Hemostatometry Using the Clot Signature Analyzer® for Assessment of Hemostasis in Cardiac Surgery , 2002, Anesthesiology.
[80] Comparison of thrombelastography with common coagulation tests. , 1981 .
[81] B. Pasche,et al. The platelet function defect of cardiopulmonary bypass. , 1993, Blood.
[82] H. Stormorken,et al. The value of activated coagulation time in monitoring heparin therapy during extracorporeal circulation. , 1984, Scandinavian journal of thoracic and cardiovascular surgery.
[83] K. Kanter,et al. Predicting and Treating Coagulopathies After Cardiopulmonary Bypass in Children , 1997, Anesthesia and analgesia.